Citation Tools

Original research
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Download to a citation manager

Cite this article as:
Coffey DG, Osman K, Aleman A, et al
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma